Suppr超能文献

在 5/6 肾切除术模型中,固有免疫和适应性免疫与肾损伤同时被逐渐激活。

Innate And Adaptive Immunity are Progressively Activated in Parallel with Renal Injury in the 5/6 Renal Ablation Model.

机构信息

Faculty of Medicine, University of São Paulo, São Paulo, Brazil.

出版信息

Sci Rep. 2017 Jun 9;7(1):3192. doi: 10.1038/s41598-017-02915-6.

Abstract

The mechanisms triggering renal inflammation in chronic kidney disease (CKD) are unclear. We performed a detailed analysis of the time course of innate and adaptive immunity activation in the 5/6 renal ablation (Nx) model. Munich-Wistar rats undergoing Nx were studied 15, 60 and 120 days after ablation. Hypertension, albuminuria, creatinine retention, interstitial expansion and infiltration by macrophages and T-lymphocytes were already evident 15 days after Nx. PCR-array was used to screen for altered gene expression, whereas gene and protein expressions of TLR4, CASP1, IL-1β and NLRP3 were individually assessed. Tlr4, Tlr5, Lbp, Nlrp3, Casp1, Irf7 and Il1b were already upregulated 15 days after Nx, while activation of Tlr2, Tlr7, Tlr9, Nod2, Tnf and Il6 was seen after 60 days post-ablation. The number of genes related to innate or adaptive immunity grew steadily with time. These observations indicate that parallel activation of innate and adaptive immunity antecedes glomerular injury and involves a growing number of intricate signaling pathways, helping to explain the difficulty in detaining renal injury in Nx as CKD advances, and, stressing the need for early treatment. Additionally, these findings may contribute to the search of therapeutic targets specific for advanced phases of CKD.

摘要

慢性肾脏病 (CKD) 中触发肾脏炎症的机制尚不清楚。我们对 5/6 肾切除术 (Nx) 模型中固有和适应性免疫激活的时程进行了详细分析。在 Nx 后 15、60 和 120 天,研究了接受 Nx 的慕尼黑-维斯塔大鼠。在 Nx 后 15 天,就已经出现了高血压、白蛋白尿、肌酐潴留、间质扩张以及巨噬细胞和 T 淋巴细胞浸润。PCR 芯片用于筛选改变的基因表达,而 TLR4、CASP1、IL-1β 和 NLRP3 的基因和蛋白表达则分别进行评估。在 Nx 后 15 天,Tlr4、Tlr5、Lbp、Nlrp3、Casp1、Irf7 和 Il1b 已经上调,而 Tlr2、Tlr7、Tlr9、Nod2、Tnf 和 Il6 的激活则在 Nx 后 60 天出现。与固有或适应性免疫相关的基因数量随着时间的推移而稳步增加。这些观察结果表明,固有和适应性免疫的平行激活先于肾小球损伤,并涉及越来越多的复杂信号通路,有助于解释为什么在 CKD 进展过程中难以阻止肾脏损伤,并且强调了早期治疗的必要性。此外,这些发现可能有助于寻找针对 CKD 晚期的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7005/5466605/7e1841547b84/41598_2017_2915_Fig1_HTML.jpg

相似文献

3
Chronic inhibition of nuclear factor-kappaB attenuates renal injury in the 5/6 renal ablation model.
Am J Physiol Renal Physiol. 2007 Jan;292(1):F92-9. doi: 10.1152/ajprenal.00184.2006. Epub 2006 Aug 8.
4
NLRP3 inflammasome inhibition ameliorates tubulointerstitial injury in the remnant kidney model.
Lab Invest. 2018 Jun;98(6):773-782. doi: 10.1038/s41374-018-0029-4. Epub 2018 Mar 6.
5
Chronic exposure to hypoxia attenuates renal injury and innate immunity activation in the remnant kidney model.
Am J Physiol Renal Physiol. 2019 Nov 1;317(5):F1285-F1292. doi: 10.1152/ajprenal.00367.2018. Epub 2019 Aug 28.
7
Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory.
Am J Physiol Renal Physiol. 2004 May;286(5):F945-54. doi: 10.1152/ajprenal.00238.2003. Epub 2003 Dec 16.
8
An extremely high dose of losartan affords superior renoprotection in the remnant model.
Kidney Int. 2005 May;67(5):1913-24. doi: 10.1111/j.1523-1755.2005.00290.x.
9
An association of losartan-hydrochlorothiazide, but not losartan-furosemide, completely arrests progressive injury in the remnant kidney.
Am J Physiol Renal Physiol. 2016 Jan 15;310(2):F135-43. doi: 10.1152/ajprenal.00388.2015. Epub 2015 Nov 4.
10
Antithrombin III prevents progression of chronic kidney disease following experimental ischaemic-reperfusion injury.
J Cell Mol Med. 2017 Dec;21(12):3506-3514. doi: 10.1111/jcmm.13261. Epub 2017 Aug 2.

引用本文的文献

4
Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activation.
J Clin Invest. 2023 Oct 2;133(19):e167517. doi: 10.1172/JCI167517.
5
Synergic Renoprotective Effects of Combined ASC Therapy with RAAS Blockade in Experimental Advanced CKD.
Stem Cells Int. 2022 Mar 25;2022:5111782. doi: 10.1155/2022/5111782. eCollection 2022.
9
Inflammation in Renal Diseases: New and Old Players.
Front Pharmacol. 2019 Oct 8;10:1192. doi: 10.3389/fphar.2019.01192. eCollection 2019.
10
Immune mechanisms of hypertension.
Nat Rev Immunol. 2019 Aug;19(8):517-532. doi: 10.1038/s41577-019-0160-5.

本文引用的文献

1
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update.
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7. doi: 10.1093/nar/gkw377. Epub 2016 May 3.
2
The NLRP3 inflammasome in kidney disease and autoimmunity.
Nephrology (Carlton). 2016 Sep;21(9):736-44. doi: 10.1111/nep.12785.
4
NLRP3 deletion protects against renal fibrosis and attenuates mitochondrial abnormality in mouse with 5/6 nephrectomy.
Am J Physiol Renal Physiol. 2016 May 15;310(10):F1081-8. doi: 10.1152/ajprenal.00534.2015. Epub 2016 Feb 17.
6
Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in mice.
Br J Pharmacol. 2016 Feb;173(4):752-65. doi: 10.1111/bph.13230. Epub 2015 Jul 31.
7
Macrophage polarization in kidney diseases.
Macrophage (Houst). 2015;2(1). doi: 10.14800/macrophage.679.
8
Altered KLOTHO and NF-κB-TNF-α Signaling Are Correlated with Nephrectomy-Induced Cognitive Impairment in Rats.
PLoS One. 2015 May 11;10(5):e0125271. doi: 10.1371/journal.pone.0125271. eCollection 2015.
9
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.
Nat Med. 2015 Mar;21(3):248-55. doi: 10.1038/nm.3806. Epub 2015 Feb 16.
10
Urea-induced ROS cause endothelial dysfunction in chronic renal failure.
Atherosclerosis. 2015 Apr;239(2):393-400. doi: 10.1016/j.atherosclerosis.2015.01.034. Epub 2015 Jan 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验